BBC News today reported that data from pharmaceutical company Eli Lilly suggests its solanezumab drug can cut the rate of the dementia’s progression by about a third in early stage patients. It is the first time that a drug has… read more »
The National Institute for Clinical Excellence has issued guidance on the mental well-being of older people in care homes. The QS50 guidance, issued in December 2013, covers older people receiving care in all care home settings, including residential and nursing… read more »
Alzheimer’s sufferers in the advanced stages of the disease could benefit from drug treatment, according to a new study published this week. The study, published in the New England Journal of Medicine, found that drugs used to slow the disease… read more »
Hundreds of thousands of people with Alzheimer’s disease who have been denied medical treatment could soon be given access to life-changing drugs on the NHS, says the Alzheimer’s Society. The National Institute for Health and Clinical Excellence (NICE) has ruled… read more »